Pub Date : 2023-01-23DOI: 10.24875/recic.m22000357
J. Valencia, Francisco Torres-Saura, Fernando Torres-Mezcua, Pascual Bordes, Javier Pineda y, J. M. Ruiz-Nodar
{"title":"Papel del bal�n farmacoactivo en el tratamiento de la trombosis muy tard�a de stent","authors":"J. Valencia, Francisco Torres-Saura, Fernando Torres-Mezcua, Pascual Bordes, Javier Pineda y, J. M. Ruiz-Nodar","doi":"10.24875/recic.m22000357","DOIUrl":"https://doi.org/10.24875/recic.m22000357","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2023-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46379067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-20DOI: 10.24875/recic.m22000358
Cristóbal A. Urbano-Carrillo
{"title":"Efecto de clase en el TAVI: ha llegado la hora de saber si son todos iguales","authors":"Cristóbal A. Urbano-Carrillo","doi":"10.24875/recic.m22000358","DOIUrl":"https://doi.org/10.24875/recic.m22000358","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2023-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47538656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-20DOI: 10.24875/recic.m22000360
O. Rodríguez-Leor, Ana Belén Cid-Álvarez, Raúl Moreno, X. Rosselló, S. Ojeda, Ana Serrador, R. López-Palop, Javier Martín-Moreiras, José Ramón Rumoroso, Á. Cequier, B. Ibáñez, I. Cruz-González, R. Romaguera, Sergio Raposeiras y, Armando Pérez de Prado
Introduction and objectives: Geographical and organizational differences between different autonomous communities (AC) can generate differences in care for ST-segment elevation myocardial infarction (STEMI). A total of 17 heart attack code programs have been compared in terms of incidence rate, clinical characteristics, reperfusion therapy, delay to reperfusion, and 30-day mortality. Methods: National prospective observational study (83 centers included in 17 infarction networks). The recruitment period was 3 months (April 1 to June 30, 2019) with clinical follow-up at 30 days. Results: 4366 patients with STEMI were included. The incidence rate was variable between different AC (P < .0001), as was gender (P = .003) and the prevalence of cardiovascular risk factors (P < .0001). Reperfusion treatment was primary angioplasty (range 77.5%-97.8%), fibrinolysis (range 0%-12.9%) or no treatment (range 2.2%13.5%). The analysis of the delay to reperfusion showed significant differences (P < .001) for all the intervals analyzed. There were significant differences in 30-days mortality that disappeared after adjusting for clinical and healthcare network characteristics. Conclusions: Large differences in STEMI care have been detected between the different AC, in terms of incidence rate, clinical characteristics, reperfusion treatment, delay until reperfusion, and 30-day mortality. The differences in mortality disappeared after adjusting for the characteristics of the patient and the care network.
{"title":"Diferencias regionales en la atenci�n al IAMCEST en Espa�a. Datos del Registro de C�digo Infarto ACI-SEC","authors":"O. Rodríguez-Leor, Ana Belén Cid-Álvarez, Raúl Moreno, X. Rosselló, S. Ojeda, Ana Serrador, R. López-Palop, Javier Martín-Moreiras, José Ramón Rumoroso, Á. Cequier, B. Ibáñez, I. Cruz-González, R. Romaguera, Sergio Raposeiras y, Armando Pérez de Prado","doi":"10.24875/recic.m22000360","DOIUrl":"https://doi.org/10.24875/recic.m22000360","url":null,"abstract":"Introduction and objectives: Geographical and organizational differences between different autonomous communities (AC) can generate differences in care for ST-segment elevation myocardial infarction (STEMI). A total of 17 heart attack code programs have been compared in terms of incidence rate, clinical characteristics, reperfusion therapy, delay to reperfusion, and 30-day mortality. Methods: National prospective observational study (83 centers included in 17 infarction networks). The recruitment period was 3 months (April 1 to June 30, 2019) with clinical follow-up at 30 days. Results: 4366 patients with STEMI were included. The incidence rate was variable between different AC (P < .0001), as was gender (P = .003) and the prevalence of cardiovascular risk factors (P < .0001). Reperfusion treatment was primary angioplasty (range 77.5%-97.8%), fibrinolysis (range 0%-12.9%) or no treatment (range 2.2%13.5%). The analysis of the delay to reperfusion showed significant differences (P < .001) for all the intervals analyzed. There were significant differences in 30-days mortality that disappeared after adjusting for clinical and healthcare network characteristics. Conclusions: Large differences in STEMI care have been detected between the different AC, in terms of incidence rate, clinical characteristics, reperfusion treatment, delay until reperfusion, and 30-day mortality. The differences in mortality disappeared after adjusting for the characteristics of the patient and the care network.","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2023-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48551632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-10DOI: 10.24875/recic.m22000289
Andrea Freixa-Benavente, Pedro Betrián-Blasco, Gemma Giralt-García, Ferran Rosés-Noguer y, Queralt Ferrer-Menduiña
{"title":"Valvuloplastia percut�nea en estenosis a�rtica grave y cr�tica en neonatos: evoluci�n y predictores de mal pron�stico","authors":"Andrea Freixa-Benavente, Pedro Betrián-Blasco, Gemma Giralt-García, Ferran Rosés-Noguer y, Queralt Ferrer-Menduiña","doi":"10.24875/recic.m22000289","DOIUrl":"https://doi.org/10.24875/recic.m22000289","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136266637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-30DOI: 10.24875/recic.m22000353
César E. Soria Jiménez, Jorge Sanz Sánchez, Molly Brooke Levine, F. Hayat, Jerway Chang y, Héctor García-García
Introduction and objectives: The role of inflammation in the pathogenesis of coronary artery disease, and that resulting from percutaneous coronary intervention (PCI) is increasingly recognized, yet the effect of colchicine in attenuating peri-PCI inflammation remains unknown. This meta-analysis investigated the efficacy of colchicine in patients undergoing PCI for secondary prevention of coronary artery disease. Methods: The Web of Science, PubMed, Ovid MEDLINE, Embase, Cochrane Central Register of Controlled Trials and ClinicalTrials. gov databases were searched. Data on studies assessing the efficacy profile of colchicine in patients undergoing PCI were pooled using a random-effects model. Results: In 13 studies of 7414 patients, no differences were observed between patients treated with colchicine compared to those without for all-cause mortality (OR, 1.1; 95%CI, 0.72-1.56; I 2 = 0%), cardiovascular mortality (OR, 0.98; 95%CI, 0.42-2.28; I 2 = 14.2%), myocardial infarction (OR, 0.84; 95%CI, 0.65-1.08; I 2 = 1.4%) or coronary revascularization (OR, 0.64; 95%CI, 0.28-1.42; I 2 = 49.3%). However, patients treated with colchicine had a lower risk of stroke (OR, 0.33; 95%CI, 0.15-0.72; I 2 = 0%).
{"title":"Resultados cl�nicos en pacientes sometidos a angioplastia coronaria percut�nea tratados con colchicina","authors":"César E. Soria Jiménez, Jorge Sanz Sánchez, Molly Brooke Levine, F. Hayat, Jerway Chang y, Héctor García-García","doi":"10.24875/recic.m22000353","DOIUrl":"https://doi.org/10.24875/recic.m22000353","url":null,"abstract":"Introduction and objectives: The role of inflammation in the pathogenesis of coronary artery disease, and that resulting from percutaneous coronary intervention (PCI) is increasingly recognized, yet the effect of colchicine in attenuating peri-PCI inflammation remains unknown. This meta-analysis investigated the efficacy of colchicine in patients undergoing PCI for secondary prevention of coronary artery disease. Methods: The Web of Science, PubMed, Ovid MEDLINE, Embase, Cochrane Central Register of Controlled Trials and ClinicalTrials. gov databases were searched. Data on studies assessing the efficacy profile of colchicine in patients undergoing PCI were pooled using a random-effects model. Results: In 13 studies of 7414 patients, no differences were observed between patients treated with colchicine compared to those without for all-cause mortality (OR, 1.1; 95%CI, 0.72-1.56; I 2 = 0%), cardiovascular mortality (OR, 0.98; 95%CI, 0.42-2.28; I 2 = 14.2%), myocardial infarction (OR, 0.84; 95%CI, 0.65-1.08; I 2 = 1.4%) or coronary revascularization (OR, 0.64; 95%CI, 0.28-1.42; I 2 = 49.3%). However, patients treated with colchicine had a lower risk of stroke (OR, 0.33; 95%CI, 0.15-0.72; I 2 = 0%).","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42677064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-23DOI: 10.24875/recic.m22000354
Pablo Salinas, M. Vázquez-Álvarez, Alfonso Jurado-Román, Sílvio Leal y, Mike Huanca
{"title":"Experiencia inicial de trombectom�a con FlowTriever en embolia aguda de pulm�n","authors":"Pablo Salinas, M. Vázquez-Álvarez, Alfonso Jurado-Román, Sílvio Leal y, Mike Huanca","doi":"10.24875/recic.m22000354","DOIUrl":"https://doi.org/10.24875/recic.m22000354","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2022-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48030676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-23DOI: 10.24875/recic.m22000355
Pablo Vidal-Calés, Omar Abdul-Jawad Altisent, Francesco Spione, Víctor Arévalos, Manel Sabaté y, S. Brugaletta
{"title":"Primera experiencia en Espa�a con el sistema PiCSO en pacientes con infarto agudo de miocardio","authors":"Pablo Vidal-Calés, Omar Abdul-Jawad Altisent, Francesco Spione, Víctor Arévalos, Manel Sabaté y, S. Brugaletta","doi":"10.24875/recic.m22000355","DOIUrl":"https://doi.org/10.24875/recic.m22000355","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2022-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44891537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-13DOI: 10.24875/recic.m22000346
Pablo Antúnez-Muiños, S. López-Tejero, Jesús Herrero Garibi, E. Díaz Peláez, Pedro Luis Sánchez Fernández y, I. Cruz-González
{"title":"Implante percut�neo de v�lvula a�rtica mediante co-registro FEops HEARTguide","authors":"Pablo Antúnez-Muiños, S. López-Tejero, Jesús Herrero Garibi, E. Díaz Peláez, Pedro Luis Sánchez Fernández y, I. Cruz-González","doi":"10.24875/recic.m22000346","DOIUrl":"https://doi.org/10.24875/recic.m22000346","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2022-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46110778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-07DOI: 10.24875/recic.m22000340
Alicia Calvo-Fernández, Josep Gómez-Lara, Roberto Elosua, Xavier Durán, H. Cubero-Gallego, Helena Tizón-Marcos, N. Salvatella, Alejandro Negrete, Raúl Millán, Consol Ivern, José Luis Díez, Andrea Sánchez-Carpintero, Núria Farré, José M. de la Torre Hernández y, B. Vaquerizo
{"title":"Alta tasa de struts no cubiertos en stents de �ltima generaci�n con pol�mero persistente, absorbible o sin pol�mero a un mes del implante","authors":"Alicia Calvo-Fernández, Josep Gómez-Lara, Roberto Elosua, Xavier Durán, H. Cubero-Gallego, Helena Tizón-Marcos, N. Salvatella, Alejandro Negrete, Raúl Millán, Consol Ivern, José Luis Díez, Andrea Sánchez-Carpintero, Núria Farré, José M. de la Torre Hernández y, B. Vaquerizo","doi":"10.24875/recic.m22000340","DOIUrl":"https://doi.org/10.24875/recic.m22000340","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2022-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48945297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：